Biostar Pharmaceuticals, Inc.

OTCPK:BSPM Stock Report

Market Cap: US$2.0

Biostar Pharmaceuticals Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Ronghua Wang

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure28yrs
CEO ownershipn/a
Management average tenure12.8yrs
Board average tenure12.5yrs

Recent management updates

No updates

Recent updates

CEO

Ronghua Wang (68 yo)

28yrs

Tenure

US$16,257

Compensation

Mr. Ronghua Wang, Ph D., has been the Chief Executive Officer and President at Biostar Pharmaceuticals, Inc. since November 1, 2007. Mr. Wang has been the Chief Executive Officer and President of Aoxing Ph...

Leadership Team

NamePositionTenureCompensationOwnership
Ronghua Wang
Chairman28yrsUS$16.26kno data
Zhenghong Wang
Chief Operating Officer12.8yrsUS$6.14kno data
Xiaojuan Zhai
Chief Financial Officer7.9yrsno datano data
Xiaohui Zheng
Chief Scientist10.4yrsno datano data
Shuang Gong
Director of Administration & Secretary of Board18yrsno datano data

12.8yrs

Average Tenure

56yo

Average Age

Experienced Management: BSPM's management team is seasoned and experienced (12.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Ronghua Wang
Chairman28yrsUS$16.26kno data
Haipeng Wu
Independent Director17.5yrsUS$9.03kno data
Zhanxiang Ma
Independent Director7.6yrsno datano data
Huiping Liao
Director7yrsno datano data
Fan Chen
Independent Directorno datano datano data

12.5yrs

Average Tenure

Experienced Board: BSPM's board of directors are seasoned and experienced ( 12.5 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/20 10:48
End of Day Share Price 2024/12/30 00:00
Earnings2017/09/30
Annual Earnings2016/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Biostar Pharmaceuticals, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Elemer PirosRodman & Renshaw, LLC